Zacks.com on MSN1d
DexCom CGM Sensor Sales to Continue Despite FDA Warning LetterDXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising ...
CGM Logo CGM LABDAQ Laboratory Information System Rated top system based on substantial count of votes by industry professionals ...
In this rapidly growing digital era, healthcare is witnessing an unprecedented transformation through artificial intelligence ...
A typical CGM detects glucose levels in the interstitial fluid with an enzyme-based sensor. The sensor converts glucose ...
The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...
Zacks.com on MSN4d
EPD Expansion Supports Abbot Stock, Macro Issues PrevailABT's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...
With substantial progress in developing its differentiated and innovative CGM and its significant market potential, Trinity Biotech’s board and management have determined that CGM technology and ...
PNC Financial Services Group Inc. raised its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.5% in the fourth ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
The urgent need for regenerative solutions to climate change, biodiversity loss, and ocean degradation has sparked a wave of ...
Analysts at William Blair reduced their Q1 2025 earnings estimates for shares of DexCom in a research note issued to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback